Developer docs
API playgroundTry for free, no card

Search company profiles

Jackson Laboratories

Full company profile

uuid000obbo

Namestring
Jackson Laboratories
Legal namestring
Jackson Laboratories Pvt. Ltd
Company typeenum
Private
Founded yearint
1980
Descriptiontext

Jackson Laboratories Pvt. Ltd. is an Indian pharmaceutical formulation manufacturer founded in 1980/1986 and headquartered in Amritsar, Punjab. The company operates two WHO-cGMP certified manufacturing units — Unit 1 in Amritsar (Punjab) with cGMP and Schedule M certification, and Unit 2 in Sansarpur Terrace (Himachal Pradesh) with WHO-GMP plus export certifications for Cambodia and Yemen — producing a portfolio of 1,000+ products across ten dosage form categories including general tablets, capsules, cephalosporin antibiotics (oral and injectable), general injectables, nutraceuticals, probiotics, eye/ear/nasal drops, veterinary products, and oral rehydration salts. Manufacturing is supported by ISO 9001:2015 and GLP certifications, a 24/7 quality control and assurance department, and advanced R&D capabilities.

The company operates a hybrid go-to-market across four revenue streams: (1) direct supply of pharmaceutical products to government medical hospitals and centers across India (Delhi, Himachal Pradesh, Punjab and others) via government tenders, (2) PCD pharma franchise distribution offering district-wise monopoly rights to franchise partners across India with entry investment of INR 1,00,000-2,00,000, (3) third-party contract manufacturing services for other pharmaceutical companies, and (4) export operations to over 10 countries across Southeast Asia, Africa, and the Middle East. The leadership consists of three directors — Jugal Kishore, Ramesh Kumar, and Sudhir Kumar — with the company structured as a privately-held Indian entity.

The business is currently in severe regulatory distress: in June 2026, manufacturing licences at both the Punjab and Himachal Pradesh units were cancelled by CDSCO and state drug regulators following investigations into spurious oxytocin injections linked to maternal deaths in Rajasthan, with 58 critical and 451 major GMP deviations identified. The company has been ordered to recall all products manufactured since April 2023 and destroy existing stocks, materially impairing all four revenue streams.

Short descriptiontext

Jackson Laboratories Pvt. Ltd. is an Indian WHO-cGMP certified pharmaceutical formulation manufacturer operating two units in Punjab and Himachal Pradesh, producing 1,000+ products across tablets, capsules, injectables, nutraceuticals, and veterinary lines, serving government hospitals, PCD franchise partners, third-party manufacturing clients, and exporters across 10+ countries.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersAmritsar, India
HQ citystring
Amritsar
HQ countrystring
India
HQ regionstring
Asia
Markets served

Serves global market

Offices3 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
pharmaceutical manufacturing, PCD pharma franchise, third party manufacturing, government tender supply, pharmaceutical exports
Industry3 codes
1Primary Care & General Medicine Pharmaceuticals
CodeHLAIAAAAPrimaryYes
2Specialty Care Pharmaceuticals
CodeHLAIAAABPrimaryNo
3Government & Public-Sector Pharmaceutical Supply (Tender/Prime Vendor)
CodeHLAIAJAFPrimaryNo
NAICS code2 codes
  • Pharmaceutical Preparation Manufacturing325412
  • Pharmaceutical and Medicine Manufacturing3254
SIC code1 code
  • Pharmaceutical Preparations2834
Product category
Pharmaceutical Manufacturing
GTM motion3 records

Each record includes

Type, Description, Source

Revenue model5 records
1Pharmaceutical Product Sales
TypeOne Time License
Description

Sale of proprietary pharmaceutical formulations including tablets, capsules, injectables, eye/ear/nasal drops, dry syrups, nutraceuticals, probiotics, and veterinary products to government hospitals, pharmacies, and healthcare providers

jacksonlaboratories.com
2PCD Pharma Franchise
TypeLicensing Royalties
Description

Monopoly PCD Pharma Franchise opportunities offering exclusive rights on a district-wise basis with franchise partners marketing and distributing products within designated territories

jacksonlaboratories.com
3Third-Party Manufacturing
TypeProfessional Services
Description

Contract manufacturing services for other pharmaceutical companies requiring manufacturing capabilities, offering production of their formulations using Jackson Laboratories' facilities

jacksonlaboratories.com
4Government Tender Supply
TypeOne Time License
Description

Supply of pharmaceutical products to government medical hospitals and centers across India including Delhi, Himachal Pradesh, Punjab, and other regions through winning government procurement contracts

jacksonlaboratories.com
5Pharmaceutical Export
TypeOne Time License
Description

Export of pharmaceutical and nutraceutical products to international markets in Southeast Asia, Africa, and the Middle East

jacksonlaboratories.com
Marketing channels4 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels4 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Supply Chain, Personnel, Operations, Infrastructure, Technology or R&D, Marketing or Sales
Pricing details1 tier
1PCD Pharma Franchise Investment
ModelOne time/ perpetual licenseBilling cadenceMulti-year contract
Notes

Investment required to start a PCD pharma franchise business ranges between INR 1,00,000-2,00,000, generally much lower compared to traditional pharma businesses

jacksonlaboratories.com
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Core offering1 text field

Jackson Laboratories manufactures and supplies a diverse portfolio of over 1,000 pharmaceutical formulations across multiple dosage forms — tablets, capsules, cephalosporin antibiotics, sterile injectables, nutraceuticals, probiotics, eye/ear/nasal drops, veterinary products, and ORS — through two WHO-cGMP certified facilities. Beyond branded manufacturing, the company offers PCD pharma franchise partnerships, government tender supply, third-party contract manufacturing, and pharmaceutical exports to 10+ countries.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 4 values shown
  • 70%+ of products available for immediate shipment
+3 more records
Product overview1 text field

Jackson Laboratories is a pharmaceutical formulation company offering a diverse portfolio of over 1,000 products across multiple dosage forms. The company's product ecosystem consists of ten core product lines: General Tablets, General Capsules, Cepha Tab/Cap/Dry Syrups (cephalosporin antibiotics), General Injectables, Cepha Injectables (sterile cephalosporin injectables), Nutraceuticals, Probiotics, Eye/Ear/Nasal Drops, Veterinary Products, and ORS. The company operates WHO-cGMP certified manufacturing facilities and serves domestic government hospitals, PCD pharma franchise partners, third-party manufacturing clients, and exports to over 10 countries across Southeast Asia, Africa, and the Middle East.

Product and service14 records
1General Tablets
CategoryPharmaceutical Formulations
Description

A comprehensive range of pharmaceutical tablets covering therapeutic areas including cardiovascular, anti-diabetic, analgesic, antibiotic, and gastrointestinal medications, supplied to government hospitals, franchise partners, and international distributors.

2General Capsules
CategoryPharmaceutical Formulations
Description

Pharmaceutical capsules including antibiotics, gastrointestinal, cardiovascular, and nutritional formulations for healthcare providers and distributors.

3Cepha Tab/Cap/Dry Syrups
CategoryPharmaceutical Formulations
Description

Cephalosporin-based antibiotics including tablets, capsules, and dry syrup formulations for anti-bacterial treatment.

4General Injectables
CategoryPharmaceutical Formulations
Description

Sterile injectable pharmaceuticals including analgesics, anti-infectives, antibiotics, cardiovascular agents, and hematinics.

5Cepha Injectables
CategoryPharmaceutical Formulations
Description

Cephalosporin-based sterile injectable antibiotics including Ceftriaxone, Cefotaxime, Cefepime, Meropenem, and Piperacillin formulations.

6Nutraceuticals
CategoryPharmaceutical Formulations
Description

Dietary supplements and nutritional products including vitamins, minerals, herbal extracts, and specialized formulations for various health conditions.

7Probiotics
CategoryPharmaceutical Formulations
Description

Probiotic supplements containing beneficial microorganisms for digestive health, immune support, and gastrointestinal condition management.

8Eye/Ear/Nasal Drops
CategoryPharmaceutical Formulations
Description

Ophthalmic and otic pharmaceutical drops including antibiotics, anti-inflammatory, and decongestant formulations.

9Veterinary Products
CategoryPharmaceutical Formulations
Description

Animal health medications including injectable antibiotics, vitamins, anti-inflammatory, and therapeutic formulations for livestock and pets.

10ORS (Oral Rehydration Salts)
CategoryPharmaceutical Formulations
Description

Oral rehydration solutions for treatment and prevention of dehydration, including flavored and unflavored formulations.

11PCD Pharma Franchise
CategoryPharmaceutical Distribution Services
Description

A franchise business model offering exclusive monopoly rights on a district-wise basis, enabling franchise partners to market and distribute Jackson Laboratories' pharmaceutical products within designated Indian territories, with an investment range of INR 1,00,000–2,00,000.

12Third-Party Pharmaceutical Manufacturing
CategoryContract Manufacturing Services
Description

Contract manufacturing services for pharmaceutical companies requiring production capabilities, with cutting-edge R&D, meticulous quality control systems, and state-of-the-art production lines across multiple dosage forms.

13Pharmaceutical Export Services
CategoryPharmaceutical Distribution Services
Description

Export of pharmaceutical and nutraceutical products to international markets across Southeast Asia, Africa, and the Middle East, with products registered in Cambodia and Yemen.

14Government Tender Supply
CategoryPharmaceutical Distribution Services
Description

Supply of pharmaceutical products to government medical hospitals and centers across India including Delhi, Himachal Pradesh, and Punjab through winning government procurement tenders.

Scale indicator5 records

Each record includes

Type, Value, Description, Source

Partnership1 partner
Strategic tierMinorTypeChannel Partner/ Reseller/ DistributorAnnounced on2026-05-01
Description

Kota-based wholesale distributor that purchased 9,300 doses of Tosin-brand oxytocin injections from Amritsar-based Jackson Laboratories and supplied to government hospitals in Kota, Rajasthan. The distributor's license was cancelled following investigation into spurious drug supply linked to maternal deaths.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight4 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Indian formulation manufacturer combining PCD pharma franchise networks, government tender supply, third-party manufacturing, and exports across diverse therapeutic categories. Operates at larger scale than Jackson but follows a closely comparable multi-channel Indian generic-formulation business model.

TypeDirect peer
Description

Indian pharmaceutical manufacturer with broad generic-formulation portfolio across tablets, capsules, and injectables, serving domestic and export markets with significant government and institutional sales overlap with Jackson Laboratories.

TypeDirect peer
Description

Indian API-to-formulation manufacturer with multi-dosage-form production, government tender participation, and emerging-market exports — closely comparable to Jackson's vertically integrated formulation model.

TypeDirect peer
Description

Mid-sized Indian formulation manufacturer with portfolio overlap in ORS, injectables, and general medicines, plus government and institutional supply channels comparable to Jackson's distribution mix.

TypeDirect peer
Description

Indian formulation manufacturer with comparable portfolio breadth (tablets, capsules, injectables, drops) and overlapping presence in government tender supply and emerging-market exports.

TypeBroad incumbent
Description

One of India's largest pharmaceutical manufacturers with extensive formulation portfolio, significant government and institutional supply, and large emerging-market export footprint — a broad incumbent operating across all of Jackson's categories at far greater scale.

TypeBroad incumbent
Description

Largest pharmaceutical company in India with comprehensive formulation manufacturing, government and institutional sales, and global exports. Competes with Jackson across most dosage forms but at vastly larger scale and broader geographic reach.

TypeBroad incumbent
Description

Major Indian generic-formulation manufacturer with strong cephalosporin and injectable franchises — directly overlapping Jackson's Cepha Injectables product line — alongside broader domestic and export channels.

TypeBroad incumbent
Description

Large Indian formulation manufacturer with therapeutic-area breadth and government/institutional channels that overlap Jackson's customer mix, though operating at significantly larger scale and with stronger export compliance.

TypeBroad incumbent
Description

Integrated Indian pharmaceutical company with formulation manufacturing, government supply contracts, and export operations across Southeast Asia, Africa, and the Middle East — overlapping Jackson's geographic and channel footprint at meaningfully larger scale.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat3 records

Each record includes

Type, Details

Key risks7 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers4 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment4 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile4 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature4 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles3 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance4 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Jackson Laboratories

Pharmaceutical Manufacturingjacksonlaboratories.com

Jackson Laboratories Pvt. Ltd. is an Indian WHO-cGMP certified pharmaceutical formulation manufacturer operating two units in Punjab and Himachal Pradesh, producing 1,000+ products across tablets, capsules, injectables, nutraceuticals, and veterinary lines, serving government hospitals, PCD franchise partners, third-party manufacturing clients, and exporters across 10+ countries.

What Jackson Laboratories does

Jackson Laboratories Pvt. Ltd. is an Indian pharmaceutical formulation manufacturer founded in 1980/1986 and headquartered in Amritsar, Punjab. The company operates two WHO-cGMP certified manufacturing units — Unit 1 in Amritsar (Punjab) with cGMP and Schedule M certification, and Unit 2 in Sansarpur Terrace (Himachal Pradesh) with WHO-GMP plus export certifications for Cambodia and Yemen — producing a portfolio of 1,000+ products across ten dosage form categories including general tablets, capsules, cephalosporin antibiotics (oral and injectable), general injectables, nutraceuticals, probiotics, eye/ear/nasal drops, veterinary products, and oral rehydration salts. Manufacturing is supported by ISO 9001:2015 and GLP certifications, a 24/7 quality control and assurance department, and advanced R&D capabilities.

The company operates a hybrid go-to-market across four revenue streams: (1) direct supply of pharmaceutical products to government medical hospitals and centers across India (Delhi, Himachal Pradesh, Punjab and others) via government tenders, (2) PCD pharma franchise distribution offering district-wise monopoly rights to franchise partners across India with entry investment of INR 1,00,000-2,00,000, (3) third-party contract manufacturing services for other pharmaceutical companies, and (4) export operations to over 10 countries across Southeast Asia, Africa, and the Middle East. The leadership consists of three directors — Jugal Kishore, Ramesh Kumar, and Sudhir Kumar — with the company structured as a privately-held Indian entity.

The business is currently in severe regulatory distress: in June 2026, manufacturing licences at both the Punjab and Himachal Pradesh units were cancelled by CDSCO and state drug regulators following investigations into spurious oxytocin injections linked to maternal deaths in Rajasthan, with 58 critical and 451 major GMP deviations identified. The company has been ordered to recall all products manufactured since April 2023 and destroy existing stocks, materially impairing all four revenue streams.

Jackson Laboratories firmographics

Firmographics
Name
Jackson Laboratories
Legal name
Jackson Laboratories Pvt. Ltd
Website
https://jacksonlaboratories.com
Company type
Private
Founded year
1980
Operating status
Operating
Headcount range
11–50 employees
Short description
Jackson Laboratories Pvt. Ltd. is an Indian WHO-cGMP certified pharmaceutical formulation manufacturer operating two units in Punjab and Himachal Pradesh, producing 1,000+ products across tablets, capsules, injectables, nutraceuticals, and veterinary lines, serving government hospitals, PCD franchise partners, third-party manufacturing clients, and exporters across 10+ countries.
Ownership category
akta.pro rank

Jackson Laboratories industry classification

Industry
Product category
Pharmaceutical Manufacturing
NAICS
Pharmaceutical Preparation Manufacturing (325412), Pharmaceutical and Medicine Manufacturing (3254)
SIC
Pharmaceutical Preparations (2834)
akta.pro primary industry
Primary Care & General Medicine Pharmaceuticals (HLAIAAAA)
akta.pro secondary industries
Specialty Care Pharmaceuticals (HLAIAAAB), Government & Public-Sector Pharmaceutical Supply (Tender/Prime Vendor) (HLAIAJAF)

Keywords

  • Pharmaceutical manufacturing
  • PCD pharma franchise
  • Third party manufacturing
  • Government tender supply
  • Pharmaceutical exports

Where Jackson Laboratories is headquartered

Location

Headquarters

HQ city
Amritsar
HQ country
India
HQ region
Asia

Offices3 records

Markets served

Jackson Laboratories business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Supply Chain, Personnel, Operations, Infrastructure, Technology or R&D, Marketing or Sales

Revenue model

  1. Pharmaceutical Product Sales: Sale of proprietary pharmaceutical formulations including tablets, capsules, injectables, eye/ear/nasal drops, dry syrups, nutraceuticals, probiotics, and veterinary products to government hospitals, pharmacies, and healthcare providers
  2. PCD Pharma Franchise: Monopoly PCD Pharma Franchise opportunities offering exclusive rights on a district-wise basis with franchise partners marketing and distributing products within designated territories
  3. Third-Party Manufacturing: Contract manufacturing services for other pharmaceutical companies requiring manufacturing capabilities, offering production of their formulations using Jackson Laboratories' facilities
  4. Government Tender Supply: Supply of pharmaceutical products to government medical hospitals and centers across India including Delhi, Himachal Pradesh, Punjab, and other regions through winning government procurement contracts
  5. Pharmaceutical Export: Export of pharmaceutical and nutraceutical products to international markets in Southeast Asia, Africa, and the Middle East

Pricing tiers

ModelBillingPrice
One time/ perpetual licenseMulti-year contractPCD Pharma Franchise Investment

Go-to-market motion3 records

Distribution channels4 records

Marketing channels4 records

Jackson Laboratories product offering

Product offering

Core offering

Jackson Laboratories manufactures and supplies a diverse portfolio of over 1,000 pharmaceutical formulations across multiple dosage forms — tablets, capsules, cephalosporin antibiotics, sterile injectables, nutraceuticals, probiotics, eye/ear/nasal drops, veterinary products, and ORS — through two WHO-cGMP certified facilities. Beyond branded manufacturing, the company offers PCD pharma franchise partnerships, government tender supply, third-party contract manufacturing, and pharmaceutical exports to 10+ countries.

Product overview

Jackson Laboratories is a pharmaceutical formulation company offering a diverse portfolio of over 1,000 products across multiple dosage forms. The company's product ecosystem consists of ten core product lines: General Tablets, General Capsules, Cepha Tab/Cap/Dry Syrups (cephalosporin antibiotics), General Injectables, Cepha Injectables (sterile cephalosporin injectables), Nutraceuticals, Probiotics, Eye/Ear/Nasal Drops, Veterinary Products, and ORS. The company operates WHO-cGMP certified manufacturing facilities and serves domestic government hospitals, PCD pharma franchise partners, third-party manufacturing clients, and exports to over 10 countries across Southeast Asia, Africa, and the Middle East.

Differentiator

Problem solved

Functional benefit

Products and services

  • General Tablets A comprehensive range of pharmaceutical tablets covering therapeutic areas including cardiovascular, anti-diabetic, analgesic, antibiotic, and gastrointestinal medications, supplied to government hospitals, franchise partners, and international distributors.
  • General Capsules Pharmaceutical capsules including antibiotics, gastrointestinal, cardiovascular, and nutritional formulations for healthcare providers and distributors.
  • Cepha Tab/Cap/Dry Syrups Cephalosporin-based antibiotics including tablets, capsules, and dry syrup formulations for anti-bacterial treatment.
  • General Injectables Sterile injectable pharmaceuticals including analgesics, anti-infectives, antibiotics, cardiovascular agents, and hematinics.
  • Cepha Injectables Cephalosporin-based sterile injectable antibiotics including Ceftriaxone, Cefotaxime, Cefepime, Meropenem, and Piperacillin formulations.
  • Nutraceuticals Dietary supplements and nutritional products including vitamins, minerals, herbal extracts, and specialized formulations for various health conditions.
  • Probiotics Probiotic supplements containing beneficial microorganisms for digestive health, immune support, and gastrointestinal condition management.
  • Eye/Ear/Nasal Drops Ophthalmic and otic pharmaceutical drops including antibiotics, anti-inflammatory, and decongestant formulations.
  • Veterinary Products Animal health medications including injectable antibiotics, vitamins, anti-inflammatory, and therapeutic formulations for livestock and pets.
  • ORS (Oral Rehydration Salts) Oral rehydration solutions for treatment and prevention of dehydration, including flavored and unflavored formulations.
  • PCD Pharma Franchise A franchise business model offering exclusive monopoly rights on a district-wise basis, enabling franchise partners to market and distribute Jackson Laboratories' pharmaceutical products within designated Indian territories, with an investment range of INR 1,00,000–2,00,000.
  • Third-Party Pharmaceutical Manufacturing Contract manufacturing services for pharmaceutical companies requiring production capabilities, with cutting-edge R&D, meticulous quality control systems, and state-of-the-art production lines across multiple dosage forms.
  • Pharmaceutical Export Services Export of pharmaceutical and nutraceutical products to international markets across Southeast Asia, Africa, and the Middle East, with products registered in Cambodia and Yemen.
  • Government Tender Supply Supply of pharmaceutical products to government medical hospitals and centers across India including Delhi, Himachal Pradesh, and Punjab through winning government procurement tenders.

Quantifiable outcome

  • 70%+ of products available for immediate shipment
  • +3 more outcomes

Companies that use Jackson Laboratories

Customer profile

Named customers4 records

Segments4 records

Ideal customer profiles4 records

Jackson Laboratories technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature4 records

Jackson Laboratories partnerships and signals

Strategic signal

Partnerships

One partnership is on record.

  • Rajasthan Medical HallminorChannel Partner/ Reseller/ Distributor · 1 May 2026Kota-based wholesale distributor that purchased 9,300 doses of Tosin-brand oxytocin injections from Amritsar-based Jackson Laboratories and supplied to government hospitals in Kota, Rajasthan. The distributor's license was cancelled following investigation into spurious drug supply linked to maternal deaths.

Scale indicators5 records

Recent moves6 records

Expansion highlights4 records

Jackson Laboratories competitors and assessment

Company assessment

Direct peers

  • Mankind Pharma: Indian formulation manufacturer combining PCD pharma franchise networks, government tender supply, third-party manufacturing, and exports across diverse therapeutic categories. Operates at larger scale than Jackson but follows a closely comparable multi-channel Indian generic-formulation business model.
  • Alkem Laboratories: Indian pharmaceutical manufacturer with broad generic-formulation portfolio across tablets, capsules, and injectables, serving domestic and export markets with significant government and institutional sales overlap with Jackson Laboratories.
  • Ipca Laboratories: Indian API-to-formulation manufacturer with multi-dosage-form production, government tender participation, and emerging-market exports — closely comparable to Jackson's vertically integrated formulation model.
  • FDC Limited: Mid-sized Indian formulation manufacturer with portfolio overlap in ORS, injectables, and general medicines, plus government and institutional supply channels comparable to Jackson's distribution mix.
  • JB Chemicals & Pharmaceuticals: Indian formulation manufacturer with comparable portfolio breadth (tablets, capsules, injectables, drops) and overlapping presence in government tender supply and emerging-market exports.

Broad incumbents

  • Cipla: One of India's largest pharmaceutical manufacturers with extensive formulation portfolio, significant government and institutional supply, and large emerging-market export footprint — a broad incumbent operating across all of Jackson's categories at far greater scale.
  • Sun Pharmaceutical Industries: Largest pharmaceutical company in India with comprehensive formulation manufacturing, government and institutional sales, and global exports. Competes with Jackson across most dosage forms but at vastly larger scale and broader geographic reach.
  • Lupin Limited: Major Indian generic-formulation manufacturer with strong cephalosporin and injectable franchises — directly overlapping Jackson's Cepha Injectables product line — alongside broader domestic and export channels.
  • Torrent Pharmaceuticals: Large Indian formulation manufacturer with therapeutic-area breadth and government/institutional channels that overlap Jackson's customer mix, though operating at significantly larger scale and with stronger export compliance.
  • Zydus Lifesciences (Cadila Healthcare): Integrated Indian pharmaceutical company with formulation manufacturing, government supply contracts, and export operations across Southeast Asia, Africa, and the Middle East — overlapping Jackson's geographic and channel footprint at meaningfully larger scale.

Market position

Strengths4 records

Weaknesses5 records

Competitive moat3 records

Key risks7 records

Key highlights6 records

Customer concentration

Jackson Laboratories social profiles

Digital presence

Jackson Laboratories compliance and trust

Trust signal

Compliance4 records

Jackson Laboratories financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Jackson Laboratories leadership team

Management profile

Number of profiles

Profiles3 records

Jackson Laboratories funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Jackson Laboratories M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Jackson Laboratories

What does Jackson Laboratories do?

Jackson Laboratories manufactures and supplies a diverse portfolio of over 1,000 pharmaceutical formulations across multiple dosage forms — tablets, capsules, cephalosporin antibiotics, sterile injectables, nutraceuticals, probiotics, eye/ear/nasal drops, veterinary products, and ORS — through two WHO-cGMP certified facilities. Beyond branded manufacturing, the company offers PCD pharma franchise partnerships, government tender supply, third-party contract manufacturing, and pharmaceutical exports to 10+ countries.

Is Jackson Laboratories a public or private company?

Jackson Laboratories is a private company. It is classified as founder individual operated bootstrapped and is currently operating.

When was Jackson Laboratories founded?

Jackson Laboratories was founded in 1980. It employs 11 to 50 people.

Where is Jackson Laboratories based?

Jackson Laboratories is headquartered in Amritsar, India, in the Asia region.

How does Jackson Laboratories make money?

Five revenue lines are on record. Pharmaceutical Product Sales are the primary driver. The others are PCD Pharma Franchise, third-Party Manufacturing, government Tender Supply and pharmaceutical Export.

Who are Jackson Laboratories's main competitors?

Direct peers on record are Mankind Pharma, Alkem Laboratories, Ipca Laboratories, FDC Limited and JB Chemicals & Pharmaceuticals. Broad incumbents are Cipla, Sun Pharmaceutical Industries, Lupin Limited, Torrent Pharmaceuticals and Zydus Lifesciences (Cadila Healthcare).

Does Jackson Laboratories have an API?

No public API is recorded for Jackson Laboratories.

What industry is Jackson Laboratories in?

Jackson Laboratories's product category is Pharmaceutical Manufacturing. Its primary akta.pro industry code is HLAIAAAA, Primary Care & General Medicine Pharmaceuticals, with a secondary code of HLAIAAAB, Specialty Care Pharmaceuticals. Its NAICS code is 325412 and its SIC code is 2834.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
The Times of IndiaJackson Labs' Baddi drug manufacturing licence restored after suspensionJackson Laboratories' Baddi unit manufacturing licence has been restored after being suspended in June, following the deaths of several women in Kota, Rajasthan, who were allegedly administered spurious oxytocin injections manufactured by the company's Punjab unit. Laboratory testing confirmed the injections contained no active oxytocin content. The Punjab facility licence remains cancelled and certain product permissions stay suspended pending compliance verification.The Times of IndiaNHRC seeks action from Rajasthan over Kota maternal deaths linked to faulty oxytocinThe NHRC has directed the Rajasthan health department to take appropriate action within eight weeks following a complaint by Jan Swasthya Abhiyan India regarding maternal deaths linked to faulty oxytocin injections. Laboratory tests found that oxytocin manufactured by Jackson Laboratories contained little to no active ingredient, along with manufacturing violations and falsified quality-control records, and the company's license has been cancelled. Survivors have faced severe long-term consequences including kidney failure requiring dialysis, while families allege they received no adequate government compensation despite depleting savings and selling assets for treatment.The Times of IndiaJackson Laboratories Oxytocin Licence: Jackson Labs Fights for License Restoration After Kota Tragedy, ETManufacturingJackson Laboratories, a Punjab-based pharmaceutical company, has filed a rejoinder with Punjab health authorities seeking restoration of its manufacturing license, which was cancelled in June after five women in Kota, Rajasthan died allegedly from a spurious Oxytocin injection found to contain no active ingredient. The company disputes the test findings and the cancellation process, citing the Kota hospital's clarification that adverse reactions were not caused by its product, and noting its product was never used in other Rajasthan locations where fatalities occurred. The case is pending before the state health secretary.The Times of IndiaJackson Labs seeks restoration of its licence - The Economic TimesJackson Laboratories, a Punjab-based pharmaceutical company, has filed a rejoinder with state health authorities seeking restoration of its manufacturing license, which was cancelled in June after an alleged spurious batch of Oxytocin was linked to the deaths of five women in Kota, Rajasthan. The company disputes the test findings and the process used to arrive at the cancellation order, refuting that its product caused the fatalities and asserting the Kota hospital confirmed adverse reactions were not occasioned by its injection. The case is pending before the state health secretary, with the company arguing its product was never used at other Rajasthan locations where deaths were reported.The Times of IndiaRajasthan Implements Stringent Drug Testing Protocols After Maternity Deaths, ETPharmaRajasthan has implemented a three-tier drug quality verification protocol after five maternity deaths occurred at Government Medical College and JK Lon Hospital in Kota between May 5-17. An investigation found that oxytocin injections manufactured by Jackson Laboratories contained no active pharmaceutical ingredient, prompting the state to refer the matter to Punjab FDA for regulatory action against the manufacturer. Unit heads across hospital departments including ICU and surgery are now made responsible for continuously verifying drug and surgical material quality.The Times of IndiaKota hospital deaths: Om Birla hands Rs 5 lakh aid to kin of deceased - The Economic TimesLok Sabha Speaker Om Birla on Saturday handed over ₹5 lakh cheques each to the families of five women who died of complications after cesarean deliveries in Kota hospitals in May. A high-level probe has been ordered into the incident, which was allegedly caused by spurious oxytocin injections, and the licence of Punjab-based Jackson Laboratories that manufactured the vials has been cancelled. The children of the deceased women will be enrolled under the state's Palanhaar Yojana, with the government pledging long-term socio-economic support beyond the one-time financial aid.The Times of IndiaSecond Drug Fails Test in Kota Maternal Deaths Probe | Jaipur News - The Times of IndiaA Dinoprostone Gel sample from Kota's New Medical College Hospital failed quality testing, with drug content found to be only about 50% of the prescribed level and inconsistent gel weight. The failed batch (H-084) was supplied by a Roorkee-based pharmaceutical company and distributed free under Rajasthan's state medicine scheme, prompting the Drug Control Department to freeze and recall the batch across Rajasthan. This development follows an earlier quality failure involving oxytocin injections manufactured by Jackson Laboratories Pvt. Ltd., which has challenged a Rajasthan health department laboratory finding in court, though officials state neither substandard drug has been linked to the five maternal deaths under investigation.The Times of IndiaRajasthan recalls labour-inducing drug after quality test failure - The Economic TimesRajasthan's Drug Control Department has recalled a batch of Dinoprostone Gel (H-084) used to induce labour after it failed a government quality test at the Drug Testing Laboratory in Jaipur, with approximately 1,117 units found in stock across medical institutions. The gel, manufactured by Cotec Healthcare Private Limited based in Roorkee, Uttarakhand, has been ordered to stop use and distribution immediately, and the company will be served notice. This incident follows a previous quality failure involving Oxytocin injections (batch 1-7881, manufactured by Jackson Laboratories) that allegedly contained no active ingredient, which has been taken up by the National Human Rights Commission.The Times of IndiaRajasthan government orders three-layer drug testing after tragedy - The Economic TimesFive women died after childbirth at Government Medical College and JK Lon Hospital in Kota, Rajasthan between May 5 and May 17, prompting an investigation that found oxytocin injections manufactured by Jackson Laboratories contained zero active pharmaceutical ingredient. The Rajasthan government is now implementing a three-tier drug quality verification system and has referred the matter to Punjab FDA for action against the manufacturer, while also taking disciplinary measures against treating doctors for lapses in care.The Indian ExpressPanel probing Kota maternal deaths flags lapses in monitoring, infection controlAn eight-member expert committee appointed by the Rajasthan government to investigate maternal deaths at government hospitals in Kota and Bikaner found procedural lapses including poor monitoring of high-risk pregnancies, missing treatment records, and gaps in infection control, but concluded the women died from different medical conditions with no single common cause linking the deaths. The investigation also revealed that Jackson Laboratories' oxytocin injections were found to contain no active ingredient, prompting the cancellation of manufacturing licenses in Punjab and Himachal Pradesh. The committee recommended strengthening hospital protocols, record-keeping practices, and drug storage procedures based on findings from both the state panel and a separate six-member AIIMS committee.